Back to funds
View filing
TCG Crossover Management, LLC
hedge fundUpdated 28 days agoManaged by Tcg Crossover Management, Llc • Latest filing Q2 2026
Portfolio value
$4.2B
Q2 2026
Filings
14
Quarterly 13F history
Top-10 concentration
100.0%
Weight of largest holdings
Annualized return
90.6%
Implied from 13F holdings
Portfolio value history
13F-disclosed portfolio value over 14 quarters
Show data table
| Period | Portfolio value |
|---|---|
| Q1 2023 | $513M |
| Q2 2023 | $609.8M |
| Q3 2023 | $679.1M |
| Q4 2023 | $901.7M |
| Q1 2024 | $1.3B |
| Q2 2024 | $959.5M |
| Q3 2024 | $1.2B |
| Q4 2024 | $1B |
| Q1 2025 | $733.1M |
| Q2 2025 | $875.5M |
| Q3 2025 | $2B |
| Q4 2025 | $3B |
| Q1 2026 | $3.5B |
| Q2 2026 | $4.2B |
Top holdings
54 positions as of Q2 2026
| # | Stock | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|---|
| 1 | A AAVXF ABIVAX SA AMERICAN DEPOSITARY SHARES | $800.6M | 6.01M | 19.24% | — |
| 2 | T TNGX TANGO THERAPEUTICS INC | $283.9M | 9.08M | 6.82% | — |
| 3 | C CGON CG ONCOLOGY INC | $260.8M | 3.67M | 6.27% | — |
| 4 | C COGT COGENT BIOSCIENCES INC | $187.9M | 4.85M | 4.52% | — |
| 5 | I IMVT IMMUNOVANT INC | $171.8M | 4.46M | 4.13% | — |
| 6 | S SYRE SPYRE THERAPEUTICS INC | $168.7M | 1.90M | 4.06% | — |
| 7 | D DNTH DIANTHUS THERAPEUTICS INC | $163.4M | 1.68M | 3.93% | — |
| 8 | M MIRM MIRUM PHARMACEUTICALS INC | $124.3M | 1.06M | 2.99% | — |
| 9 | Z ZLAB ZAI LAB LTD-ADR | $116.6M | 6.14M | 2.80% | — |
| 10 | A AMLX AMYLYX PHARMACEUTICALS INC | $112.1M | 6.24M | 2.70% | — |
| 11 | M MNST MONTE ROSA THERAPEUTICS INC | $111.9M | 4.62M | 2.69% | — |
| 12 | B BCRX BIOCRYST PHARMACEUTICALS INC | $110.2M | 11.02M | 2.65% | — |
| 13 | V VOR VOR BIOPHARMA INC | $104.4M | 5.67M | 2.51% | — |
| 14 | T TYRA TYRA BIOSCIENCES INC | $103.8M | 3.25M | 2.49% | — |
| 15 | D DYN DYNE THERAPEUTICS INC | $102.5M | 4.62M | 2.46% | — |
| 16 | I IRON DISC MEDICINE INC | $98.1M | 1.34M | 2.36% | — |
| 17 | R RLAY RELAY THERAPEUTICS INC | $80M | 4.27M | 1.92% | — |
| 18 | S SVRA SAVARA INC | $76.2M | 12.36M | 1.83% | — |
| 19 | A AURA AURA BIOSCIENCES INC | $67.7M | 9.53M | 1.63% | — |
| 20 | R RVMDW REVOLUTION MEDICINES INC | $63.8M | 340.9K | 1.53% | — |